Blog Search

New Wall Street Journal Editorial Calls the Demand to Reduce Drug Prices a “Medical Innovation Threat”

An editorial published yesterday in the Wall Street Journal argues that calls to reduce prices of new drugs is the latest threat to medical innovation. With pharmaceutical companies subject to a seemingly endless approval process and a narrow window of pr…
An editorial published yesterday in the Wall Street Journal argues that calls to reduce prices of new drugs is the latest threat to medical innovation. With pharmaceutical com… http://mylifeisworthit.org/blog/2014/08/new-wall-street-journal-editorial-calls-demand-reduce-drug-prices-medical-innovation-threat/

Huffington Post: "Our Lives Are Worth It" by Bob Tufts

In his July 31 blog, "Drugs and Dollars," David Blumenthal, president of The Commonwealth Fund, writes about the cost of new targeted medical therapeutics. He sees the advantages of these new treatments but warns that, "the prospect of spending so much on…
Originally published on the HuffPost Impact Blog. In his July 31 blog, "Drugs and Dollars," David Blumenthal, president of The Commonwealth Fund, writes about the cost of n… http://mylifeisworthit.org/blog/2014/08/huffington-post-our-lives-are-worth-it/

Patient Advocacy Groups: Despite the Affordable Care Act, Insurers Still Working to Limit Patient Drug Access

A strongly worded letter to Health and Human Services Secretary Sylvia Mathews Burwell, signed by more than 300 patient advocacy groups, accuses insurance providers of employing discriminatory policies designed to limit patient access to certain essential…
A strongly worded letter to Health and Human Services Secretary Sylvia Mathews Burwell, signed by more than 300 patient advocacy groups, accuses insurance providers of employing d… http://mylifeisworthit.org/blog/2014/08/patient-advocacy-groups-despite-affordable-care-act-insurers-still-working-limit-patient-drug-access/

Forbes: Medical Innovation is Key to Containing Rising Healthcare Costs

Innovative treatments not only save lives – they save money. A newly published editorial in Forbes by pharmaceutical executive and chemist John Lechleiter illustrates how past medical triumphs, such as the Salk polio vaccine and anti-retroviral treatments…
Innovative treatments not only save lives – they save money. A newly published editorial in Forbes by pharmaceutical executive and chemist John Lechleiter illustrates how past med… http://mylifeisworthit.org/blog/2014/08/forbes-medical-innovation-key-containing-rising-healthcare-costs/

« Previous 12 Next »